*

Market Insights

Stock screens updated daily — built in Wright’s visual language.

Stock screens updated daily — built in Wright’s visual language.

Top Growth Stocks

"Growth" stocks refer to companies that are expected to grow at a faster rate than the average market. These stocks typically have high earnings growth potential and reinvest their profits back into the business rather than paying dividends to shareholders. Key characteristics of growth stocks include strong revenue and earnings growth, innovative business models, and a focus on expanding market share. They are often found in sectors such as technology, healthcare, and consumer discretionary.

Updated:
Ticker Security Name ⇅ PrevClose Beta MarketCap PE Ratio ⇅ Dividend Yield PBV Ratio ⇅ Category
ANANTRAJ Anant Raj Ltd. 551.1 1.016 16771.467 41.322 0.002 4.211 Mid-Cap
CGCL Capri Global Capital Ltd. 183.96 0.306 13125.966 33.256 0.001 3.143 Mid-Cap
ASTRAZEN Astrazeneca Pharma India Ltd. 8340.0 0.434 19188.844 191.205 0.003 27.144 Mid-Cap
CHOICEIN Choice International Ltd. 820.2 0.376 9596.442 62.893 0.0 10.351 Mid-Cap
CCL CCL Products (India) Ltd. 942.4 0.609 7616.44 26.774 0.008 4.033 Mid-Cap
ASTRAMICRO Astra Microwave Products Ltd. 986.7 1.073 5916.031 42.517 0.003 5.797 Mid-Cap
CENTURYPLY Century Plyboards (India) Ltd. 770.5 0.969 15684.282 71.174 0.001 6.679 Mid-Cap
AURIONPRO Aurionpro Solutions Ltd. 1055.4 0.775 7208.391 38.373 0.001 4.928 Mid-Cap
ALKYLAMINE Alkyl Amines Chemicals Ltd. 1557.6 0.933 8315.731 44.924 0.006 6.091 Mid-Cap
CAPLIPOINT Caplin Point Laboratories Ltd. 1813.5 0.752 14000.958 26.302 0.003 5.291 Mid-Cap
No data found for this filter.

Select a filter to view information.

Details

About Anant Raj Ltd. and Its Industry:

Anant Raj Ltd. is a real estate development company based in India. With a strong presence in both residential and commercial segments, the company is known for its innovative projects and focus on sustainable development. Anant Raj Ltd. has established itself as a reliable player in the real estate industry, delivering quality infrastructure and creating value for its customers. Challenges faced by Anant Raj Ltd. include navigating through the dynamic regulatory environment in the real estate sector, managing construction costs amidst market fluctuations, and competition from other players in the industry. However, the company also has significant opportunities for growth, such as leveraging technology to enhance operations, expanding into new geographic markets, and focusing on sustainable development practices to attract environmentally conscious customers.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹551.1
    • Market Cap: ₹16771.467
    • Category: Mid-Cap
    • Beta: 1.016
  • P/E Ratio: 41.322
  • Dividend Yield: 0.002%
  • Price-to-Book Value (PBV): 4.211

About Capri Global Capital Ltd. and Its Industry:

Capri Global Capital Ltd. is a financial services company that specializes in providing a wide range of financial products and services to individuals, small and medium enterprises, and micro, small, and medium enterprises (MSMEs). The company operates in various segments, including retail finance, affordable housing finance, and SME lending. Capri Global Capital has established itself as a significant player in the industry by offering innovative financial solutions tailored to the unique needs of its diverse client base. Challenges facing Capri Global Capital Ltd. include increasing competition in the financial services sector, regulatory changes impacting lending practices, and economic uncertainties affecting borrower creditworthiness.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹183.96
    • Market Cap: ₹13125.966
    • Category: Mid-Cap
    • Beta: 0.306
  • P/E Ratio: 33.256
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 3.143

About Astrazeneca Pharma India Ltd. and Its Industry:

Astrazeneca Pharma India Ltd. is a leading pharmaceutical company operating in India. It is known for its focus on research and development, producing a wide range of pharmaceutical products that cater to various medical needs. The company plays a crucial role in the healthcare industry by providing innovative medicines and therapies that contribute to improving the well-being of individuals and communities. Despite its prominent position, Astrazeneca Pharma India Ltd. faces challenges in navigating regulatory complexities in the pharmaceutical sector and maintaining competitive pricing amidst market fluctuations. However, it also has significant opportunities for growth and expansion, especially in tapping into the increasing demand for advanced healthcare solutions and exploring strategic partnerships and acquisitions to enhance its market presence.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹8340.0
    • Market Cap: ₹19188.844
    • Category: Mid-Cap
    • Beta: 0.434
  • P/E Ratio: 191.205
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 27.144

About Choice International Ltd. and Its Industry:

Choice International Ltd. is a diversified financial services company that offers a wide range of investment products and services to its clients. With a strong presence in the market, the company serves both individual and institutional investors, providing tailored solutions to meet various financial needs. Choice International Ltd. is known for its commitment to customer service, innovative financial products, and a well-rounded approach to wealth management within the industry. In the highly competitive financial services industry, Choice International Ltd. faces challenges in standing out among numerous rivals offering similar services. Adapting to rapidly changing market trends, regulatory changes, and economic uncertainties presents ongoing challenges for the company. Balancing the need for technological advancements while maintaining a personalized touch in client relationships is also a key challenge.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹820.2
    • Market Cap: ₹9596.442
    • Category: Mid-Cap
    • Beta: 0.376
  • P/E Ratio: 62.893
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 10.351

About CCL Products (India) Ltd. and Its Industry:

CCL Products (India) Ltd. is a leading Indian company in the coffee sector, specializing in the manufacturing and exporting of instant coffee. With a global presence in more than 90 countries, the company has established itself as a key player in the industry. CCL Products is known for its high-quality products, innovative approach to coffee processing, and strong focus on sustainability practices, making it a reputable name in the market. Challenges and opportunities lie ahead for CCL Products within the competitive coffee industry. Some challenges the company may face include fluctuating coffee prices, changing consumer preferences and demands, and increasing competition from both traditional and emerging coffee brands.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹942.4
    • Market Cap: ₹7616.44
    • Category: Mid-Cap
    • Beta: 0.609
  • P/E Ratio: 26.774
  • Dividend Yield: 0.008%
  • Price-to-Book Value (PBV): 4.033

About Astra Microwave Products Ltd. and Its Industry:

Astra Microwave Products Ltd. is a leading Indian company in the field of RF and microwave electronics, catering to sectors like defense, space, telecommunications, and broadcasting. The company specializes in designing, developing, and manufacturing a wide range of high-performance RF and microwave components and systems, including amplifiers, antennas, transceivers, and radar systems. Astra Microwave has established a strong reputation for its quality products, technological innovation, and reliable solutions, making it a trusted partner for critical applications in the industry. Challenges facing Astra Microwave Products Ltd. include intense competition in the RF and microwave electronics sector, requiring the company to continually innovate and differentiate itself to maintain market share.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹986.7
    • Market Cap: ₹5916.031
    • Category: Mid-Cap
    • Beta: 1.073
  • P/E Ratio: 42.517
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.797

About Century Plyboards (India) Ltd. and Its Industry:

Century Plyboards (India) Ltd. is a leading manufacturer of plywood, laminates, and related products in India. The company has a strong presence in both residential and commercial markets, providing high-quality building materials for construction and interior design projects. With a focus on innovation and sustainability, Century Plyboards has established itself as a trusted brand known for its durable and aesthetically pleasing products. Their wide range of offerings caters to diverse customer needs, making them a reliable choice for both individual consumers and businesses in the construction industry. As with many companies in the manufacturing sector, Century Plyboards faces challenges such as fluctuating raw material costs and changing regulatory environments.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹770.5
    • Market Cap: ₹15684.282
    • Category: Mid-Cap
    • Beta: 0.969
  • P/E Ratio: 71.174
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 6.679

About Aurionpro Solutions Ltd. and Its Industry:

Aurionpro Solutions Ltd. is a technology company that specializes in providing solutions for digital innovation and enterprise security. Operating across multiple industries, Aurionpro offers services such as digital banking, cybersecurity, and data management to help organizations enhance their technological capabilities and secure their operations. With a focus on innovation and cutting-edge solutions, Aurionpro has established itself as a key player in the technology services sector. Challenges facing Aurionpro Solutions Ltd. include intense competition in the rapidly evolving technology landscape, requiring the company to continuously innovate and differentiate its offerings to stay ahead. Additionally, the need to adapt to changing market demands and emerging technologies poses a challenge for Aurionpro to effectively navigate and capitalize on new opportunities within the industry.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1055.4
    • Market Cap: ₹7208.391
    • Category: Mid-Cap
    • Beta: 0.775
  • P/E Ratio: 38.373
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 4.928

About Alkyl Amines Chemicals Ltd. and Its Industry:

Alkyl Amines Chemicals Ltd. is a leading chemical manufacturing company that specializes in producing a range of amines and amine-based chemicals. With a strong presence in the chemical industry, the company plays a vital role in providing high-quality chemicals that are utilized in various sectors such as pharmaceuticals, agrochemicals, and surfactants. Alkyl Amines Chemicals Ltd. is known for its commitment to innovation, quality, and sustainability in its operations, making it a preferred partner for many companies seeking reliable chemical solutions. The company faces challenges in navigating the complexities of the global chemical market, including fluctuating raw material prices, regulatory changes, and intense competition.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1557.6
    • Market Cap: ₹8315.731
    • Category: Mid-Cap
    • Beta: 0.933
  • P/E Ratio: 44.924
  • Dividend Yield: 0.006%
  • Price-to-Book Value (PBV): 6.091

About Caplin Point Laboratories Ltd. and Its Industry:

Caplin Point Laboratories Ltd. is a pharmaceutical company that specializes in the manufacturing and distribution of generic pharmaceutical products. Based in India, the company has a global footprint, exporting its products to over 60 countries worldwide. Caplin Point is known for its focus on high-quality and affordable medicines, catering to a wide range of therapeutic categories such as antihypertensives, anticonvulsants, antimicrobials, and more. With a strong emphasis on research and development, the company consistently introduces new products to meet the evolving needs of the healthcare market. In facing the challenges of the pharmaceutical industry, Caplin Point must navigate stringent regulatory requirements across various jurisdictions, ensuring compliance while maintaining operational efficiency.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1813.5
    • Market Cap: ₹14000.958
    • Category: Mid-Cap
    • Beta: 0.752
  • P/E Ratio: 26.302
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.291